Patent intelligence · US
US 11033494
Apparatuses containing an emulsion and methods of manufacture
Apparatuses containing an emulsion and methods of manufacture
Patent details — US 11033494
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jun 15, 2021
- Expiration
- Jun 10, 2041
- Applicant
- Recursion Pharmaceuticals, Inc.
- Claims
- 9
- CPC classes
- A61K, A61K9/0087, A61K9/107
Quick answer
US 11033494 (Apparatuses containing an emulsion and methods of manufacture) is held by Recursion Pharmaceuticals, Inc.. Status: granted. Granted Jun 15, 2021. Expires Jun 10, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Recursion Pharmaceuticals, Inc.
- Grant date
- Expiration
- Claims
- 9
- CPC classes
- A61K, A61K9/0087, A61K9/107
More from Recursion Pharmaceuticals, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 11919868
Heterocyclic compounds and related methods
granted -
US 6331564
Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease
expired -
US 6028103
Triaryl methane compounds and analogues thereof useful for the treatment or prevention of sickle cell disease or diseases characterized by abnormal cell proliferation
expired
Frequently asked questions
What is US patent 11033494?
US 11033494 (Apparatuses containing an emulsion and methods of manufacture) is held by Recursion Pharmaceuticals, Inc.. Status: granted. Granted Jun 15, 2021. Expires Jun 10, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11033494?
Recursion Pharmaceuticals, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 4 pharmaceutical patents for this assignee.
When does US 11033494 expire?
Our index shows an expiration date of Jun 10, 2041 (15 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.